Doxa AB
STO:DOXA
Doxa AB
Inventory
Doxa AB
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Doxa AB
STO:DOXA
|
Inventory
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
OssDsign AB
STO:OSSD
|
Inventory
kr22.7m
|
CAGR 3-Years
73%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
|
Xvivo Perfusion AB
STO:XVIVO
|
Inventory
kr248.5m
|
CAGR 3-Years
33%
|
CAGR 5-Years
33%
|
CAGR 10-Years
24%
|
|
|
Bactiguard Holding AB
STO:BACTI B
|
Inventory
kr21.9m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
V
|
Vimian Group AB
STO:VIMIAN
|
Inventory
€80.1m
|
CAGR 3-Years
9%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
S
|
S2Medical AB (publ)
STO:S2M
|
Inventory
kr1.4m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Doxa AB
Glance View
Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2014-04-07. The firm develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
See Also
What is Doxa AB's Inventory?
Inventory
0
SEK
Based on the financial report for Dec 31, 2025, Doxa AB's Inventory amounts to 0 SEK.
